Family Medicine · Burbank, CA
NPI
1114102993
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
303 S Glenoaks Blvd, Suite 6
Burbank, CA, 91502
Phone (818) 842-8400
Groups this clinician bills Medicare through
Medicare paid, 2024
$359K
25,709 services
Medicare patients, 2024
621
Average age 72
Drug cost, 2024
$5.7M
59,720 prescriptions
Company payments, 2025
$2,466
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zarine Ter-Poghosyan was code J0585 (injection, onabotulinumtoxina, 1 unit), 15,655 times for 67 patients. In total Zarine Ter-Poghosyan billed 25,709 services in 54 codes, and Medicare paid $359K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 15,655 | 67 | $4.98 | $78K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2,672 | 266 | $0.75 | $2,009 |
| 36415 Venipuncture Blood Collection | Office | 2,002 | 582 | $8.65 | $17K |
| 99213 Office E&M - Established | Office | 1,685 | 554 | $71.80 | $121K |
| 82947 Clinical Chemistry | Office | 725 | 265 | $3.85 | $2,791 |
| 20610 Joint Injection | Office | 567 | 228 | $41.71 | $24K |
| 99212 Office E&M - Established | Office | 530 | 293 | $46.15 | $24K |
| 99214 Office E&M - Established | Office | 356 | 250 | $98.70 | $35K |
| 96372 Injection Administration | Office | 292 | 108 | $12.02 | $3,511 |
| 96116 Behavioral Health Services | Office | 200 | 192 | $70.58 | $14K |
| 64615 Musculoskeletal | Office | 101 | 67 | $126.26 | $13K |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 97 | 42 | $86.88 | $8,428 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 75 | 46 | $0.94 | $70.38 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 72 | 11 | $0.35 | $24.96 |
| 94640 Treatment - Miscellaneous | Office | 71 | 60 | $6.89 | $489 |
By year: 2022 $281K for 19,126 services; 2023 $318K for 20,640 services; 2024 $359K for 25,709 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,002 | 582 | $8.65 | $17K |
| 82947 Clinical Chemistry | 725 | 265 | $3.85 | $2,791 |
Medicare prescription drug claims, 2024
In 2024, the drug Zarine Ter-Poghosyan prescribed most often to Medicare patients was Atorvastatin Calcium, with 3,212 prescriptions and refills. In total Zarine Ter-Poghosyan wrote 59,720 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 3,212 | 3,544 | 371 | $7,572 |
| Gabapentin Generic | 3,125 | 3,333 | 349 | $6,117 |
| Amlodipine Besylate Generic | 1,901 | 2,163 | 228 | $1,484 |
| Metoprolol Succinate Generic | 1,757 | 2,006 | 203 | $6,461 |
| Meclizine Hcl Generic | 1,591 | 1,645 | 178 | $11K |
| Losartan Potassium Generic | 1,569 | 1,812 | 184 | $3,789 |
| Omeprazole Generic | 1,473 | 1,620 | 176 | $3,137 |
| Metformin Hcl Generic | 1,392 | 1,633 | 184 | $13K |
| Meloxicam Generic | 1,352 | 1,400 | 162 | $1,429 |
| Lorazepam Generic | 1,317 | 1,340 | 192 | $2,034 |
| Rosuvastatin Calcium Generic | 1,119 | 1,298 | 142 | $4,626 |
| Pantoprazole Sodium Generic | 1,118 | 1,236 | 146 | $3,221 |
| Tamsulosin Hcl Generic | 1,100 | 1,194 | 133 | $3,327 |
| Ibuprofen Generic | 1,091 | 1,133 | 171 | $4,542 |
| Levothyroxine Sodium Generic | 828 | 945 | 91 | $2,505 |
Brand drugs: 9,532 claims; generic drugs: 48,919 claims; opioid claims: 531.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zarine Ter-Poghosyan $2,466 ($2,466 in general payments such as food, travel and fees) from 29 companies. The largest payer was Amgen Inc. with $345.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 18 | $345 |
| Abbvie Inc. ABBV | 14 | $234 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $160 |
| Sumitomo Pharma America, Inc. 4506.T | 7 | $156 |
| Ardelyx, Inc. ARDX | 5 | $138 |
| Axsome Therapeutics, Inc. AXSM | 5 | $116 |
| GlaxoSmithKline, LLC. GSK | 5 | $114 |
| Pfizer Inc. PFE | 5 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $94.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.